CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Meet the Editorial Board Member117
Meet the Regional Editor77
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation66
Breaking Barriers: Advanced Pharmacological Mediators for Neuropsychiatric Disorders61
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis61
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease39
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 38
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation36
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives36
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus36
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis33
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer’s Disease33
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies30
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease30
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment30
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota29
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review29
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia26
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders25
From Microbes to Minds: The Impact of Gut Bacteria on Infant Cognitive Growth24
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches24
Microbiota-Gut-Brain Axis: A Novel Paradigm in the Neurobiology of Anxiety24
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and Targeted Therapeutics22
0.98524212837219